ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Georgia » Gastroenterology

Top Gastroenterology Prescribers in Georgia

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
BENJAMIN JOHNSTON MD

Gastroenterology

14,441

$692K

555
310 are 65+

10%
patients receiving schedule two controlled substances

Avg: 0%

26%
patients receiving schedule three controlled substances

Avg: 0%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 33%

$48
Average prescription price

Avg: $117

MARIO RAVRY M.D.

Gastroenterology

8,551

$559K

640
593 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 33%

$65
Average prescription price

Avg: $117

JACINTO DEL MAZO M.D.

Gastroenterology

8,127

$493K

368
304 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

6%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 33%

$61
Average prescription price

Avg: $117

JOHN NORTHUP M.D.

Gastroenterology

7,464

$495K

361
250 are 65+

5%
patients receiving schedule two controlled substances

Avg: 0%

20%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 33%

$66
Average prescription price

Avg: $117

AHMAD IRFAN M.D.

Gastroenterology

7,250

$942K

1168
731 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 33%

$130
Average prescription price

Avg: $117

THOMAS DEMARCO MD

Gastroenterology

5,407

$312K

315
282 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 33%

$58
Average prescription price

Avg: $117

STEPHEN FINN MD

Gastroenterology

5,083

$312K

1141
739 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

1%
patients receiving schedule three controlled substances

Avg: 0%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 33%

$61
Average prescription price

Avg: $117

GEORGE GOLDIN MD

Gastroenterology

4,314

$359K

1022
718 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

1%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 33%

$83
Average prescription price

Avg: $117

DON ROBERTS M.D.

Gastroenterology

4,241

$384K

692
493 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 0%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 33%

$91
Average prescription price

Avg: $117

MICHAEL DAWSON M.D.

Gastroenterology

4,071

$485K

702
447 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 0%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

34%
prescriptions for brand name drugs

Avg: 33%

$119
Average prescription price

Avg: $117

DAVID GRYBOSKI M.D.

Gastroenterology

3,752

$304K

860
749 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 33%

$81
Average prescription price

Avg: $117

JASMINE JEFFERS M.D.

Gastroenterology

3,615

$257K

344
215 are 65+

7%
patients receiving schedule two controlled substances

Avg: 0%

9%
patients receiving schedule three controlled substances

Avg: 0%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 33%

$71
Average prescription price

Avg: $117

GREGORY SMITH MEDICAL DOCTOR

Gastroenterology

3,310

$732K

524
342 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

33%
prescriptions for brand name drugs

Avg: 33%

$221
Average prescription price

Avg: $117

MICHAEL GALAMBOS M.D.

Gastroenterology

3,251

$744K

664
515 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 33%

$229
Average prescription price

Avg: $117

GREGORY BORAK MD

Gastroenterology

3,191

$319K

743
624 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 33%

$100
Average prescription price

Avg: $117

MARK MURPHY MD

Gastroenterology

2,999

$651K

502
403 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

40%
prescriptions for brand name drugs

Avg: 33%

$217
Average prescription price

Avg: $117

PRAVINCHANDRA PATEL M.D.

Gastroenterology

2,917

$390K

700
437 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 33%

$134
Average prescription price

Avg: $117

JAMES SPIVEY M.D.

Gastroenterology

2,891

$594K

369
217 are 65+

4%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 33%

$205
Average prescription price

Avg: $117

C WOODS M.D.

Gastroenterology

2,845

$276K

574
433 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 33%

$97
Average prescription price

Avg: $117

ROSE CESAR MD

Gastroenterology

2,683

$207K

530
391 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 33%

$77
Average prescription price

Avg: $117

DANIEL MARCADIS M.D.

Gastroenterology

2,669

$326K

336
227 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 33%

$122
Average prescription price

Avg: $117

BRYAN WOODS M.D.

Gastroenterology

2,664

$211K

499
414 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 33%

$79
Average prescription price

Avg: $117

SHERAJ JACOB MD

Gastroenterology

2,615

$328K

551
411 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 33%

$125
Average prescription price

Avg: $117

SCOTT CLARK MD

Gastroenterology

2,515

$316K

460
364 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 33%

$126
Average prescription price

Avg: $117

STEVEN CARPENTER MD

Gastroenterology

2,507

$223K

443
339 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 33%

$89
Average prescription price

Avg: $117

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank